2,879
Views
0
CrossRef citations to date
0
Altmetric
Review Article

The oncological and reproductive outcomes of fertility-preserving treatments for stage 1 grade 1 endometrial carcinoma: a systematic review and meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon &
Article: 2294329 | Received 18 Feb 2023, Accepted 30 Nov 2023, Published online: 21 Dec 2023

Figures & data

Figure 1. PRISMA flow diagram.

Figure 1. PRISMA flow diagram.

Figure 2. Remission rate (A), relapse rate (B) and proportion of live births (C) following fertility-preserving treatment in endometrial cancer.

Figure 2. Remission rate (A), relapse rate (B) and proportion of live births (C) following fertility-preserving treatment in endometrial cancer.

Figure 3. Remission rate (A), relapse rate (B) and proportion of live births (C) following oral progesterone therapy. Remission rate (D), relapse rate (E) and proportion of live births (F) following hysteroscopic resection and adjuvant progesterone therapy. Remission rate (G), relapse rate (H) and proportion of live births (I) following intrauterine progesterone therapy.

Figure 3. Remission rate (A), relapse rate (B) and proportion of live births (C) following oral progesterone therapy. Remission rate (D), relapse rate (E) and proportion of live births (F) following hysteroscopic resection and adjuvant progesterone therapy. Remission rate (G), relapse rate (H) and proportion of live births (I) following intrauterine progesterone therapy.
Supplemental material

Supplemental Material

Download MS Word (10.9 KB)

Supplemental Material

Download MS Word (13.3 KB)

Data availability statement

The data that support the findings of this study are available from the corresponding author, MO, upon reasonable request.